In the dynamic world of pharmacovigilance, staying compliant with local and global regulatory requirements is both critical and challenging. Local literature monitoring (LLM) is a cornerstone of this process, ensuring adverse events are identified and reported from regional journals and publications. However, traditional methods of LLM are often labor-intensive, time-consuming, and prone to errors.
Enter Crypta, the GenAI-powered Literature Monitoring Platform, designed to redefine how you approach pharmacovigilance workflows. Whether you are a Global Pharma/Biotech company or a Service Provider, Crypta adds unparalleled value, delivering efficiency gains and significant cost reductions.
Challenges in Local Literature Monitoring
Manual Effort: Scanning hundreds of local journals and databases manually is tedious and error-prone.
High Costs: Employing dedicated teams to handle LLM inflates operational costs.
Regulatory Complexity: Varying global and local regulatory requirements demand meticulous attention.
Time-Consuming Process: Delays in identifying adverse events can impact compliance and patient safety.
These challenges not only strain resources but also expose organizations to compliance risks.
How Crypta Transforms Local Literature Monitoring?
Crypta leverages cutting-edge Generative AI and automation to streamline LLM processes.
Here’s how it delivers value:
1. Automated Literature Import and Analysis
Crypta automates the import of local and global journal articles, saving hours of manual effort. Using advanced NLP algorithms, it scans articles for relevant information, including:
Adverse events
Drug mentions
Patient and reporter details
2. Intelligent Adverse Event Detection
Its AI-powered engine ensures precise detection of Individual Case Safety Reports (ICSRs), minimizing false positives and missed cases.
3. Customizable Workflows
The platform supports highly customizable workflows tailored to your organization's specific regulatory requirements, enabling seamless integration into existing systems.
4. Time-Efficient Summaries and Translations
Crypta auto-generates summaries and provides multilingual support, including translation of abstracts and full-text articles, making global operations simpler.
5. Regulatory Compliance
Crypta is 21 CFR Part 11 compliant, ensuring robust audit trails and secure data handling.
Efficiency Gains and Cost Reductions with Crypta
Efficiency Gains
50–70% Reduction in Manual Effort: By automating repetitive tasks like journal scanning and ICSR detection, Crypta enables your team to focus on high-value tasks.
Real-Time Monitoring: Reduces delays in identifying adverse events, improving compliance.
Enhanced Accuracy: Minimizes human errors, ensuring reliable outputs.
Cost Reductions
Lower Operational Costs: Crypta reduces the need for large teams, cutting overheads by up to 40%.
Optimized Resource Utilization: Teams can handle higher volumes of literature without proportional increases in resources.
Elimination of Penalties: By ensuring timely and accurate regulatory reporting, Crypta mitigates the risk of fines or non-compliance costs.
Real-World Impact
Case Study: A leading pharma company implemented Crypta across its regional pharmacovigilance teams. Results included:
65% decrease in time spent on local literature review.
$500,000 annual savings in operational costs.
Zero compliance issues during regulatory audits.
Why Choose Crypta?
Scalable and Flexible: Suited for both global pharma companies and niche service providers.
Proven Expertise: Built on years of experience in pharmacovigilance and AI technologies.
Seamless Integration: Crypta works with your existing systems and supports a range of databases and journals.
Conclusion
For global pharma/biotech companies and service providers, Crypta is more than a tool—it’s a transformational platform. By automating and optimizing the local literature monitoring process, Crypta ensures compliance, enhances operational efficiency, and delivers tangible cost savings.
The question isn’t whether you can afford to implement Crypta, but whether you can afford not to.
Ready to transform your pharmacovigilance processes? Contact us today to learn more about Crypta and request a demo!
Comments